A Multicentre Open-Label trial with High-dose Canakinumab Vs Tocilizumab for Severe COVID-19 (CANTOVID trial)

Project

Overview

Contributors

TOMBETTI ENRICO   Scientific Manager  

Departments involved

Type

FON_NAZ - Bandi Altre Fondazioni

Funder

FONDAZIONE FRATELLI CONFALONIERI
External Organization Funding Organization

Date/time interval

October 1, 2020 - September 30, 2025

Project duration

60 months

Research Areas

Concepts


Settore MED/09 - Medicina Interna